ARCHIVES

HPV-Positive Women Over 30 Should Be Retested Within Two Years

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

More DCT Concepts Approved By Advisors

July 10, 1992

Cancer Surveillance: risk Factors Explain SF Breast Cancer Rates

July 25, 1997

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

January 20, 2006

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

December 12, 2003

NCI-Approved Clinical Trials

March 31, 2006

In Brief: NIH Study Finds Intramural Program Tenures Few Minorities, Calls For Improvements

March 11, 1994